Viewing Study NCT04103892


Ignite Creation Date: 2025-12-24 @ 3:38 PM
Ignite Modification Date: 2026-01-09 @ 2:01 AM
Study NCT ID: NCT04103892
Status: COMPLETED
Last Update Posted: 2025-10-14
First Post: 2019-09-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study
Sponsor: Clexio Biosciences Ltd.
Organization: